Navigation Links
LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects
Date:9/13/2011

f clinical trials, and the potential therapeutic and commercial potential, of LX4211. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX4211 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Unless specifically indicated otherwise, results reported as trends were not statistically significant. Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
2. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
3. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
4. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
5. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
6. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
9. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015 The leading companies in ... global cardiac rhythm management device market dominate their ... Medtronic, St. Jude Medical, Boston Scientific and Asahi ... market segment. The healthcare market research publisher,s report, ... 2015 as a base year, providing forecasts for ...
(Date:5/22/2015)... KING OF PRUSSIA, Pa. , May 22, 2015 ... CSL Behring its 2015 Corporate Leadership Award as ... science and improving the care of the bleeding disorders community.  ... and Managing Director, CSL Limited, during the NHF Annual Spring ... May 21. "The National Hemophilia Foundation is dedicated ...
(Date:5/22/2015)... , May 20, 2015 Research ... of the "Guide to Prepare Application Dossiers ... China (2014 Edition) " report to their ... is one of segment market of the most ... overseas medical device manufacturers and producers to penetrate ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
(Date:5/24/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... which will allow them to take pressure measurements in ... bladder function. The doctor usually orders it if they ... overactive bladder (OAB). , Women’s Excellence in ... have problems with unwanted urinary leakage or problems with ...
(Date:5/24/2015)... 2015 ProPin is a set of ... X. Utilize ProPin to pin point locations on a map, ... , ProPin allows users to choose from 30 simplistic presets ... With on-screen controls, video editors can easily manipulate ProPin presets as ... mark with absolute ease. , Using ProPin is easy, simply drag ...
(Date:5/24/2015)... Santa Rosa, CA (PRWEB) May 24, 2015 ... gives a clear indicator that the single best option ... This study reveals that fitness level was the single ... researchers accounted for variables such as diabetes and family ... the significance of maintaining lifelong heart and lung fitness. ...
(Date:5/23/2015)... With the implementation of the Affordable ... increasingly difficult to provide their employees with a viable ... insurance for employees stand to face strict penalties. Never ... part of a business’s success or failure. In an ... USA Doctors has created a varying level of less ...
(Date:5/23/2015)... 2015 A live auction will be held ... surgery centers and other medical facilities around the United States. ... lab, radiology, surgery, anesthesia, exam and much more. , ... Thursday, May 28 starting at 9:00am CDT each day. The ... 25th Avenue, Melrose Park, IL 60160. Anyone can participate ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2
... the Nissan Quest,and their families can breathe easy when ... is thanks to micronAir(R) combination filters - a,product of ... on the Quest. The combination filters from micronAir ... the HVAC system, reducing offensive odors as well as,gaseous ...
... Amsterdam, November 6, 2007 Elsevier announced ... AG, headquartered in Leverkusen, Germany, has signed an ... electronic format for the first time, EMBASE Classic ... 43 Excerpta Medica Abstract Journals published between 1947 ...
... vitamins and electrolytes offer healthiest ... benefits in new functional water, PLANO, Texas, Nov. ... punch, Snapple,s introduction of Antioxidant Water and,LYTeWater takes drinking water to ... smart solution that,improves energy, helps restore the body and supports a ...
... Micromet, Inc. (Nasdaq:,MITI), a biopharmaceutical company ... cancer, inflammation and autoimmune diseases,announced the publication ... mode of,action of Micromet,s bispecific BiTE antibody ... of Immunotherapy(1) and in Cancer Immunology,Immunotherapy(2), respectively. ...
... BioElectronics,Corporation, (Pink Sheets: BIEL), announced today that Michael ... Vice President of Sales. Mr. Seidenman is ... well versed in electro medicine devices. He brings ... device sales,management. Mr. Seidenman has launched many new ...
... Nov. 6 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc.,(,Lorus,), a ... of pharmaceutical products and,technologies for the management of ... at 10:30 a.m. EST (Eastern Standard Time), Dr.,Aiping ... corporate overview of the,Company at the Acumen BioFin ...
Cached Medicine News:Health News:Quality Control: Nissan Quest to Feature micronAir(R) Combination Cabin Air Filters 2Health News:EMBASE Classic makes inroads into pharmaceutical industry 2Health News:Snapple's New Antioxidant Water and LYTeWater Take Hydration to the Next Level 2Health News:Snapple's New Antioxidant Water and LYTeWater Take Hydration to the Next Level 3Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 2Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 3Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 4Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 5Health News:BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales 2Health News:Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference 2
... represents the latest in green laser technology, and ... both the operating room and clinic. Designed in ... premium 532nm photocoagulator. , ,The Solitaire is a ... flexibility to deliver up to 2.0 W despite ...
... wide range of innovative features, including HEINE's ... (U.S. Patent #4,684,227). Stereopsis is maximized in ... unique Diffuser aperture absorbs only 30% of ... simplifying difficult examinations. A newly incorporated yellow ...
... Heart 2006 is a long-term ... recorder. This device is the ... cardiac symptoms and their correlation to ... reliable, it provides 2 lead loop ...
The latest addition to Aerotels Transtelephonic ECG product line, HeartOne™ is a unique miniaturized single-lead, 4-event recorder/transmitter designed for transmission on cellular (GSM) and an...
Medicine Products: